FDA Grants Orphan Drug Designation to Biodel’s Glucagon for Prevention of Hypoglycemia in Congenital Hyperinsulinism Population
[at noodls] – FDA Grants Orphan Drug Designation to Biodel’s Glucagon for Prevention of Hypoglycemia in Congenital Hyperinsulinism Population DANBURY, Conn., Dec. 6, 2012 (GLOBE NEWSWIRE) — Biodel Inc. (Nasdaq:BIOD) … more
View todays social media effects on BIOD
View the latest stocks trending across Twitter. Click to view dashboard